WHO ICTRP trial
A clinical trial to study the efficacy of Rifaximin in improving the quality of…
CTRI/2009/091/000979 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2009/091/000979 |
|---|---|
| Public title | A clinical trial to study the efficacy of Rifaximin in improving the quality of life and treating encephalopathy in patients with cirrhosis and minimal hepatic encephalopathy |
| Scientific title | PROSPECTIVE RANDOMIZED, DOUBLE BLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF RIFAXIMIN ON PSYCHOMETRIC TEST PERFORMANCE AND QUALITY OF LIFE IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY Acronym: RIME |
| Primary sponsor | Dr Sandeep Sidhu Professor Department of Gastroenterology DMC and Hospital, Ludhiana. Punjab Tel: 0161- 2402855 Cell: 9814025085, Fax: 0161-2302620 Email- [email protected] |
| Secondary sponsors | Study drugs supplied by M/s LUPIN limited, Laxmi towers, Plot No. C-25, C wing, 4th floor, Bandra Kurla Complex, Mumbai- 400051 |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Interventions | Intervention1: Rifaximin: Rifaximin 1200 mg per day for 8 weeks, orally Control Intervention1: Placebo: |
| Registration date | Feb 12, 2009 |
| Target size | 100 |
| Secondary IDs | U1111-1111-3609 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: